21 October 2026  |  New York, USA

100 Participants

20Speakers

20+ Jurisdictions

FreeAttendance

GCR Live: Antitrust in Life Sciences 2026

GCR Live: Antitrust in Life Sciences returns for its 6th edition - bringing together the sharpest minds from across the global life sciences and competition community. 

This high‑impact event cuts through the noise to deliver clear, actionable insight into the fast‑evolving antitrust issues shaping pharmaceuticals, biotech, medical devices, and the wider innovation ecosystem. Delegates will hear directly from leading enforcers, practitioners, economists, and industry insiders, gaining practical guidance on navigating today’s most complex challenges. 

Expect dynamic discussions, strategic takeaways, and unrivalled opportunities to connect with peers from private practice, government, and the life sciences industry. 

Join us to stay ahead in one of the most rapidly shifting areas of antitrust. 

Co-Chairs

David Blackburn
David Blackburn
Director
National Economic Research Associates

Rahul Rao
Rahul Rao
Partner
White & Case

Pricing

FREE TO ATTEND

What our delegates say about GCR Live

Highly relevant and interesting topics and discussion. Good balance of panel presentation and questions, including from the audience."

Paul Fehlner
Chief Intellectual Property Counsel
Spyre Therapeutics

GCR Events Code of Conduct

We are committed to fostering a safe, inclusive, and welcoming environment for everyone. We believe that every attendee contributes to the overall quality and experience of our events. Respect and courtesy are fundamental to our community.

We do not tolerate any form of discrimination or harassment towards any of our staff, clients or suppliers.

2026 Sponsors

 

platinium Sponsor

Gold SponsorS

SILVER Sponsor

Supporting Organisations

Meet the GCR team

Rebecca Bird
Content lead

Graham Day
Sponsorship lead

Gabrielle Howell
Operations lead

Herieth Mbade
Marketing lead

Want to find out more about GCR?

Register to receive regular round-up emails and limited access to selected news and content.